iScience (Feb 2021)

E-cigarettes compromise the gut barrier and trigger inflammation

  • Aditi Sharma,
  • Jasper Lee,
  • Ayden G. Fonseca,
  • Alex Moshensky,
  • Taha Kothari,
  • Ibrahim M. Sayed,
  • Stella-Rita Ibeawuchi,
  • Rama F. Pranadinata,
  • Jason Ear,
  • Debashis Sahoo,
  • Laura E. Crotty-Alexander,
  • Pradipta Ghosh,
  • Soumita Das

Journal volume & issue
Vol. 24, no. 2
p. 102035

Abstract

Read online

Summary: E-cigarette usage continues to rise, yet the safety of e-cigarette aerosols is questioned. Using murine models of acute and chronic e-cigarette aerosol inhalation, murine colon transcriptomics, and murine and human gut-derived organoids in co-culture models, we assessed the effects of e-cigarette use on the gut barrier. Histologic and transcriptome analyses revealed that chronic, but not acute, nicotine-free e-cigarette use increased inflammation and reduced expression of tight junction (TJ) markers. Exposure of murine and human enteroid-derived monolayers (EDMs) to nicotine-free e-cigarette aerosols alone or in co-culture with bacteria also causes barrier disruption, downregulation of TJ protein, and enhanced inflammation in response to infection. These data highlight the harmful effects of “non-nicotine” component of e-cigarettes on the gut barrier. Considering the importance of an intact gut barrier for host fitness and the impact of gut mucosal inflammation on a multitude of chronic diseases, these findings are broadly relevant to both medicine and public health.

Keywords